Evaluation of the Efficacy of 2% Cyclosporine in Preventing Graft Rejection
NCT02206789
·
clinicaltrials.gov ↗
NA
Phase
UNKNOWN
Status
200
Enrollment
OTHER
Sponsor class
Conditions
Corneal Graft Rejection
Interventions
DRUG:
Prednisolone acetate1%,
DRUG:
Prednisolone acetate1%, cyclosporine 2%
Sponsor
Aravind Eye Care System